Hoth Therapeutics (NASDAQ:HOTH) is a biopharmaceutical company focused on developing innovative therapies for patients battling conditions ranging from dermatological disorders to chronic diseases. Dedicated to improving patient care, Hoth Therapeutics invests in research and development to bring novel treatments from the laboratory to the clinic. Their projects include potential therapies for acne, eczema, chronic wound disorders, and more, aiming to address unmet medical needs in these areas. Operating with a mission to enhance patient quality of life through groundbreaking medical solutions, Hoth Therapeutics continues to push the boundaries of science to offer hope and advance healthcare outcomes.